These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Analogs of natural nucleosides and their 5'-triphosphates carrying the amino group in 3'-position--highly effective inhibitors of replication, repair and transcription]. KraevskiÄ AA; Kochetkova SV; Azhaev AV Mol Biol (Mosk); 1985; 19(1):173-6. PubMed ID: 2580224 [TBL] [Abstract][Full Text] [Related]
63. Intragenomic localization of carcinogen-DNA damage. Wogan GN; McMahon G Basic Life Sci; 1986; 38():127-34. PubMed ID: 3741326 [No Abstract] [Full Text] [Related]
64. Investigative approaches for the analysis of drug interactions at the genetic level. Latt SA; Allen JW Ann N Y Acad Sci; 1976; 281():40-9. PubMed ID: 798528 [No Abstract] [Full Text] [Related]
65. [Pharmacology of drugs of abuse]. Haen E; Wodarz N Internist (Berl); 1999 Jun; 40(6):605-10. PubMed ID: 10420313 [No Abstract] [Full Text] [Related]
66. DNA fragmentation and DNA repair of mammalian cells as an indicator for the complex interactions between carcinogens and modulating factors. Stich HF; Whiting RF; Wei L; San RH Pharmacol Rev; 1978 Dec; 30(4):493-9. PubMed ID: 392543 [No Abstract] [Full Text] [Related]
67. Actions of 4-nitroquinoline 1-oxide on eucaryotic cells: molecular and cellular studies. Ikenaga M; Takebe H Carcinog Compr Surv; 1981; 6():65-91. PubMed ID: 6786746 [No Abstract] [Full Text] [Related]
68. Genetic effects of coumarins. Grigg GW Mutat Res; 1977-1978; 47(3-4):161-81. PubMed ID: 80745 [No Abstract] [Full Text] [Related]
69. The pharmacology of mood-altering drugs of abuse. Carr LA Prim Care; 1993 Mar; 20(1):19-31. PubMed ID: 8464940 [TBL] [Abstract][Full Text] [Related]
70. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Coppola M; Mondola R Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606 [TBL] [Abstract][Full Text] [Related]
71. The potential utility of some legal highs in CNS disorders. Davidson C; Schifano F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510 [TBL] [Abstract][Full Text] [Related]
72. [Conformation changes of DNA modified by chemical agents]. Daune M Biochimie; 1978; 60(10):1097-110. PubMed ID: 367449 [No Abstract] [Full Text] [Related]
73. Some aspects of chemical mutagenesis in man and in Drosophila. Obe G; Sperling K; Belitz HJ Angew Chem Int Ed Engl; 1971 May; 10(5):302-14. PubMed ID: 5005242 [No Abstract] [Full Text] [Related]
74. Recent physiochemical and quantum chemical studies on drugs of abuse and relevant biomolecules. Kaufman JJ NIDA Res Monogr; 1978; (22):250-77. PubMed ID: 30909 [No Abstract] [Full Text] [Related]
75. The use of choice procedures for assessing the reinforcing properties of drugs in humans. Johanson CE; de Wit H NIDA Res Monogr; 1989; 92():171-210. PubMed ID: 2512492 [No Abstract] [Full Text] [Related]
76. Molecular targets of chemical mutagens. Preston BD; Doshi R Adv Exp Med Biol; 1991; 283():193-209. PubMed ID: 2068985 [No Abstract] [Full Text] [Related]
77. Pharmacokinetic and pharmacodynamic drug interactions: implications for abuse liability testing. Sellers EM; Busto U; Kaplan HL NIDA Res Monogr; 1989; 92():287-306. PubMed ID: 2512498 [No Abstract] [Full Text] [Related]
78. Drug impairment reviews: other drugs--general. Smart R NIDA Res Monogr; 1977 Mar; Series 11():100-12. PubMed ID: 408689 [No Abstract] [Full Text] [Related]